Use access key #2 to skip to page content.
$20.56 -1.22 (-5.60%)
12/1/2008 2:03 PM

Auxilium Pharmaceuticals, Inc. (AUXL)

CAPS Rating:
*

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

View All Commentary (AUXL)

Recs

1

Avatar 21popsontop (< 20) Submitted: 1/28/08 10:13 PM : Underperform Start Price: $32.05 AUXL Score: -2.07

Down Down Down we go until we start seeing some positive cash flow.(Net profit margine minus - 50%) (Income minus - 42 million)Not even a dividend to keep any investor interest.Positives are no dept and it is gaining in sales growth,but you have to start showing a profit at some point to stay in business and management does not seem to understand that.All I make of this is another institutional pump and dump.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links